Somatostatinoma Treatment Market Future Prospects and Opportunity Assessment Upto 2027
Somatostatinoma is an extremely rare pancreatic neuroendocrine tumor (PNET) or duodenal endocrine tumor (DNET), which originates either in the pancreas (50%) or the gastrointestinal tract (50%).
Report overview @ https://www.transparencymarketresearch.com/somatostatinoma-treatment-market.html
Based on data published in the National Center for Biotechnology Information, an estimated incidence rate of Somatostatinoma is of 1/40,000,000 globally.
Companies are investing in research to develop innovative and effective treatment procedures. For instance, In June 2018, Boehringer Ingelheim announced to invest US$ 270 Mn to build a new Biologicals Development Center (BDC) specialized for immunology and immune-oncology. The initiatives like these are expected to fuel the market growth during the forecast period.
Request a Brochure of Somatostatinoma Treatment Market Report –
Key Drivers and Restraints of Global Somatostatinoma Treatment Market
The adoption rate of drugs for treatment of Somatostatinoma rises with increase in prevalence of the disease. Majority, that is three-quarters (78%), of somatostatinomas are malignant and the great majority of these (70%–92%) is present with metastatic disease.
Ongoing research activities throughout the world propel the market. Ga labeled radionucleotide therapies and radiofrequency ablation technique, are the major factors driving the demand for somatostatinoma treatment.
The major restraining factor of the somatostatinoma treatment market is high cost of treatment. The treatment of somatostatinoma is not available in every hospital; moreover, it is very expensive.
Combination Drug Therapy to Witness High Demand
Based on treatment type, the global somatostatinoma treatment market can be segmented into combination drug therapy, surgical, radiofrequency ablation (RFA), transarterial embolization, and others
Combination drug therapy accounted for highest market share in 2018. The treatment usually consists of combination of intravenous 5-fluorouracil (5-FU) and streptozotocin drugs. However, Doxorubicin and 5-FU have also been used and may be a more effective combination for the treatment of somatostatinoma.
For More Actionable Insights into The Competitive Landscape of Somatostatinoma Treatment Market , Pre Book This Report –
Specialty Clinics Segment to Witness Highest Growth
Based on end-user, the global somatostatinoma treatment market can be divided into: hospitals, specialty clinics, and cancer & radiation therapy centers
In terms of revenue, hospitals dominated the market in 2018, due to large number of procedures performed in these facilities
The specialty clinics segment is anticipated to grow with the highest CAGR during the forecast period. This can be attributed to the presence of developed technologies and availability of multiple options for somatostatinoma diagnosis and treatments.
Various market players are also collaborating with medical institutions and research centers to provide educational services to health care professionals to help them enhance their skills
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Somatostatinoma Treatment Market Future Prospects and Opportunity Assessment Upto 2027 here
News-ID: 1899309 • Views: 100
More Releases from Transparency Market Research
Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ https://www.transparencymarketresearch.com/flavored-syrup-market.html Increasing demand of flavored syrups especially among the consumers contributes to the